In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...

The global pharmaceutical market is set to surpass a total value of US$1.75 trillion by the end of the decade, according to ...

Drug candidates don't usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up ...

Top executives can steer large pharma companies in many ways. Here are the ones who employees approve of the most.

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Few would place Recursion Pharmaceuticals ( RXRX +8.44%), a little-known biotech company, in the same league as these tech ...

A Press Release from Issue One provides evidence from tax filings showing how big pharmaceutical companies, including Eli Lilly, Merck, and Pfizer, use their trade association Pharmaceutical Research ...